CABP7 anticorps (N-Term)
Aperçu rapide pour CABP7 anticorps (N-Term) (ABIN783667)
Antigène
Voir toutes CABP7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, mouse, rat
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- 15 amino acid peptide near the amino terminus of human CaBP7
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store the antibody (in aliquots) at -20 °C.
-
-
- CABP7 (Calcium Binding Protein 7 (CABP7))
-
Autre désignation
- CABP7
-
Sujet
- Calcium binding proteins (CaBP) play a crucial role in the calcium-mediated cellular signal transduction pathway in the central nervous system. The CaBP family shares much similarity with CaM I (calmodulin), and it has been shown that CaBP proteins can substitute functionally for, and possibly augment the function of, CaM I. CaBP7 (Calcium-binding protein 7), contains two EF-hand domains for calcium binding and shares 70 % homology with CaBP8 and 50 % homology with CaM I. It negatively regulates Golgi-to-plasma membrane trafficking by interacting with PI4KB and inhibiting its activity. CaBP7 and 8 possess a targeting mechanism that is unique amongst the CaBPs that may contribute to differential functional Ca2+-sensing by these family members.Synonyms: Calcium-binding protein 7
-
ID gène
- 164633
-
NCBI Accession
- NP_872333
-
UniProt
- Q86V35
Antigène
-